Related Experiment Video

Updated: Aug 11, 2026

Induction of Acute Ischemic Stroke in Mice Using the Distal Middle Artery Occlusion Technique
07:34

Induction of Acute Ischemic Stroke in Mice Using the Distal Middle Artery Occlusion Technique

Published on: December 15, 2023

How and when do we alter inflammatory mechanisms in stroke? Will it help?

Thomas J DeGraba1

  • 1Department of Neurology, Uniformed Services University of the Health Sciences, Bethesda, MD 20889, USA.

Seminars in Neurology
|February 16, 2006
PubMed

Insights

Atherosclerosis is a chronic inflammatory disease. Targeting these inflammatory mechanisms may reduce the risk of atherothrombotic stroke by addressing plaque formation and activation.

Area of Science:

  • Cardiovascular Medicine
  • Inflammation Research
  • Neurology

Background:

  • Atherosclerosis is increasingly understood as a chronic inflammatory condition.
  • This perspective offers new therapeutic avenues for preventing atherothrombotic stroke.
  • Understanding plaque development and activation is key to stroke risk reduction.

Purpose of the Study:

  • To explore the role of inflammation in atherosclerosis and atherothrombotic stroke.
  • To identify inflammatory markers predictive of stroke risk.
  • To review current and future anti-inflammatory treatment strategies for stroke prevention.

Main Methods:

  • Literature review of key inflammatory elements in atherosclerosis.
  • Analysis of pathophysiological mechanisms of plaque initiation, formation, and activation.
  • Evaluation of existing pharmacotherapies and future anti-inflammatory approaches.

Main Results:

  • Key inflammatory mediators in atherosclerosis and atherothrombotic stroke were identified.
  • Potential inflammatory biomarkers for stroke risk stratification were discussed.
  • The impact of current medications on atherosclerotic inflammation and stroke was reviewed.

Conclusions:

  • Altering inflammatory pathways in atherosclerosis presents a promising strategy for reducing atherothrombotic stroke risk.
  • Further research into inflammatory mechanisms and targeted therapies is warranted.
  • Pharmacotherapeutic interventions aimed at inflammation hold potential for primary and secondary stroke prevention.

More Related Videos

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model08:22

Isolation and Flow Cytometric Assessment of Neuroimmune Interactions in a Mini-Stroke Murine Model

Published on: June 20, 2025

Related Concept Videos

Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Ischemic Stroke l: Introduction01:15

Ischemic Stroke l: Introduction

Ischemic stroke is an acute cerebrovascular condition in which blood flow to a brain region is suddenly interrupted, leading to tissue infarction. Neurons depend on continuous oxygen and glucose supply, so even brief reductions in perfusion cause energy failure, ionic imbalance, and irreversible injury. Ischemic strokes are classified into thrombotic and embolic types based on their underlying mechanisms.Thrombotic MechanismsThrombotic stroke develops when a clot forms within a cerebral artery.
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
Clot Retraction and Fibrinolysis01:16

Clot Retraction and Fibrinolysis

After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.